Covidien Receives FDA 510(k) Clearance For Nellcor Pulse Oximeters
Covidien, a global provider of patient monitoring and respiratory care devices, has received US FDA 510(k) clearance with labelling for the use of its Nellcor pulse oximeters in newborn screening for critical congenital heart disease (CCHD). Covidien devices that feature the new CCHD labels include Nellcor Bedside SpO2 patient monitoring system; Nellcor Bedside respiratory patient…